BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3443224)

  • 21. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pirenzepine and cimetidine for duodenal ulcers. A comparative randomised double-blind controlled study.
    Simjee AE; Bhoola RL; Spitaels JM; Manion GL
    S Afr Med J; 1988 Nov; 74(9):446-7. PubMed ID: 3055362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
    Young MD; Lottes SR; Webb LA
    Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of duodenal ulcer.
    Eliakim R; Rachmilewitz D
    Rev Clin Basic Pharm; 1985; 5(3-4):215-33. PubMed ID: 2881325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment and prevention of recurrence of duodenal ulcer with pirenzepin and cimetidine].
    Eichenberger PM; Giger M; Mattle W; Pelloni S; Müller-Lissner SA; Gonvers JJ; Birchler R; Blum AL
    Schweiz Med Wochenschr; 1982 Jan; 112(1):25-30. PubMed ID: 7036336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative effectiveness of ranitidine (150 mg X 2) and cimetidine (400 mg x 2) in the treatment of acute duodenal ulcer. A French multicenter controlled clinical trial].
    Cortot A; Henry-Amar M; Pappo M; Paris JC
    Gastroenterol Clin Biol; 1987 Feb; 11(2):136-41. PubMed ID: 3552845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
    Pöch G; Londong W
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
    Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W
    Digestion; 1988; 40(1):25-32. PubMed ID: 3234616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interim analysis of a comparative trial of ranitidine and cimetidine in the prevention of duodenal ulcer.
    Gough KR
    Am J Med; 1984 Nov; 77(5B):39-42. PubMed ID: 6095660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duodenal ulcer recurrences after treatment with pirenzepine and ranitidine.
    Dzieniszewski J; Knapik Z; Pokora J; Kosieradzki W; Jarosz O; Woźniak-Stolarska B; Radwan P
    Mater Med Pol; 1987; 19(3):196-9. PubMed ID: 3450981
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A combination of pirenzepine with ranitidine in the treatment of refractory duodenal ulcer].
    Calabrò A; Salvadori G; Parenti S; Sani S; Ceccatelli P; Valentini P; Surrenti C
    Minerva Dietol Gastroenterol; 1986; 32(3):291-5. PubMed ID: 3796871
    [No Abstract]   [Full Text] [Related]  

  • 34. Pirenzepine in long-term therapy for duodenal ulcer.
    Capria A; Bresci G; Polloni A; Rindi G; Geloni M; Del Tacca M
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):422-4. PubMed ID: 6688799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in "non-responders".
    Dal Monte PR; D'Imperio M; Ferri M; Fratucello F; del Soldato P
    Hepatogastroenterology; 1985 Jun; 32(3):126-8. PubMed ID: 3839484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychologic predictors of duodenal ulcer healing.
    Levenstein S; Prantera C; Scribano ML; Varvo V; Berto E; Spinella S
    J Clin Gastroenterol; 1996 Mar; 22(2):84-9. PubMed ID: 8742643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined therapy using ranitidine and sucralfate in duodenal ulcer resistant to cimetidine].
    Uribarrena R; Arín A; Valera JI; Oreja M; Burusco MJ; Pueyo A; Fortún MT
    Rev Clin Esp; 1990 Apr; 186(7):328-31. PubMed ID: 2392595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effective drugs and less effective drugs in the treatment of duodenal ulcer].
    Ligny G; Van Cauter J
    Acta Gastroenterol Belg; 1984; 47(6):569-75. PubMed ID: 6100349
    [No Abstract]   [Full Text] [Related]  

  • 39. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ranitidine, cimetidine and placebo in the short and longer term treatment of duodenal ulcer].
    Klinger J; Maggiolo P; Goić A
    Rev Med Chil; 1984 Apr; 112(4):337-41. PubMed ID: 6091211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.